Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

Why do I call them gamblers??? Because they

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
keekee Member Profile
 
Followed By 107
Posts 4,097
Boards Moderated 0
Alias Born 09/29/11
160x600 placeholder
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems GlobeNewswire Inc. - 1/14/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 9:24:22 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/18/2020 9:22:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 5:15:40 PM
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors GlobeNewswire Inc. - 12/17/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/4/2020 6:05:19 AM
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submissi... GlobeNewswire Inc. - 12/2/2020 1:22:29 PM
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil GlobeNewswire Inc. - 11/13/2020 4:40:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 5:11:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:17:04 PM
Chembio Diagnostics Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/5/2020 4:05:00 PM
Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire Inc. - 10/23/2020 8:00:10 AM
Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System GlobeNewswire Inc. - 10/15/2020 5:55:10 PM
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System GlobeNewswire Inc. - 10/2/2020 7:26:09 AM
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System GlobeNewswire Inc. - 9/8/2020 6:01:08 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 7:43:29 AM
Chembio Diagnostics Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 7:19:40 AM
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020 GlobeNewswire Inc. - 7/23/2020 4:10:10 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 10:00:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 9:43:40 AM
Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues GlobeNewswire Inc. - 7/6/2020 4:23:03 PM
Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen Sy... GlobeNewswire Inc. - 7/6/2020 4:11:10 PM
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System GlobeNewswire Inc. - 7/6/2020 4:10:10 PM
Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results GlobeNewswire Inc. - 7/1/2020 5:00:10 PM
keekee   Monday, 08/31/20 01:19:02 PM
Re: keekee post# 416
Post # of 456 
Why do I call them gamblers??? Because they are BLIND, DUMB GAMBLERS, only able to eke out because they have bottomless funds and avenues of hiding the mounting losses until a lucky hit emerge.

Since I discovered that there was a clear hangups and conspiracy to steal my trading data for the purpose of trading against me and my partners, we have generally emerged on the green side. We lost out late last year and earlier this year when we did not know that these Securities fraudsters were in illegal conspiracy against us. Well, now we know. And we will expose them to the SEC, potentially court action, and put all details in our book, including the specific names of these market makers. Final post for today. But we have a trail.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences